WAVERLY ADVISORS, LLC – BioCryst Pharmaceuticals, Inc. Transaction History
WAVERLY ADVISORS, LLC portfolio value:
$313,000
portfolio value
WAVERLY ADVISORS, LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.87% | -5.05K shares | -4K | $12.6 | 24.87K |
| Q2 2022 | share | Increase | +0.17% | 50 shares | -169K | $10.58 | 29.92K |
| Q1 2022 | share | 0.00% | 0 shares | -46K | $16.26 | 29.87K | |
| Q4 2021 | share | 0.00% | 0 shares | 163K | $13.79 | 29.87K | |
| Q3 2021 | share | 0.00% | 0 shares | -114K | $14.37 | 29.87K | |
| Q2 2021 | share | 0.00% | 0 shares | 66K | $15.81 | 29.87K | |
| Q1 2021 | share | Increase | +33.22% | 7.45K shares | 211K | $10.17 | 29.87K |
| Q4 2020 | share | Decrease | -4.27% | -1K shares | 117K | $7.45 | 22.42K |
| Q3 2020 | share | 0.00% | 0 shares | -19K | $3.44 | 23.42K | |
| Q2 2020 | share | 0.00% | 0 shares | 61K | $4.76 | 23.42K | |
| Q1 2020 | share | Increase | +4.46% | 1K shares | -20K | $2 | 23.42K |
| Q4 2019 | share | 0.00% | 0 shares | 3K | $3.45 | 22.42K | |
| Q3 2019 | share | 0.00% | 0 shares | -21K | $2.87 | 22.42K | |
| Q2 2019 | share | 0.00% | 0 shares | -98K | $3.79 | 22.42K | |
| Q1 2019 | share | 0.00% | 0 shares | 2K | $8.14 | 22.42K | |
| Q4 2018 | share | 0.00% | 0 shares | 10K | $8.07 | 22.42K | |
| Q3 2018 | share | Increase | 0.00% | 22.42K shares | 171K | $7.63 | 22.42K |
| Q1 2018 | share | Decrease | -100.00% | -12.13K shares | -60K | $4.77 | 0 |
| Q4 2017 | share | Increase | 0.00% | 12.13K shares | 60K | $4.91 | 12.13K |